ArticleJAMA network open2026
Preferences for Infection Prevention in Hospital-Acquired Infections.
Article in JAMA network open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Importance: Hospital-acquired infections worsen health care outcomes and increase costs. The decision-making process guiding selection of infection prevention practices for hospital-acquired infections is not well understood; understanding how health care professionals prioritize infection prevention practices is critical for guiding efficient and equitable implementation. Objective: To determine the characteristics of infection control practices that affect health care professional decision-making. Design, Setting, and Participants: This survey study was a discrete choice experiment conducted between February 27 and March 27, 2025, with data analyzed from March 28 to June 3, 2025. Health care professionals who had participated in infection prevention and control decision-making identified through authorship in related journals were eligible to participate. Attributes were identified through literature review and expert consultation. Data were analyzed using mixed logit and latent class models. Scenario and relative attribute importance analyses were performed to explore heterogeneity in preferences. Main Outcome and Measures: Respondents chose between infection control practices varying in 4 attributes: quality of clinical evidence, economic costs and benefits, implementation duration, and additional time required per patient. Preference weights, relative attribute importance, and probability of clinical practice uptake were assessed. Results: A total of 256 respondents were included (161 male [62.9%]), with a median age group of 40 to 49 years (84 [32.8%]) and mostly from high-income countries (160 [62.5%]). Respondents preferred infection prevention practices with strong clinical evidence, shorter implementation durations, lower time burdens, and favorable cost-effectiveness profiles. Two latent classes were identified: evidence seekers in low- and middle-income countries who prioritized high-quality evidence and showed high willingness to adopt practices, and efficiency seekers, including respondents from high-income countries who were more selective and prioritized cost-effectiveness. Economic costs and benefits were consistently the most important attribute across all regions, with marked regional variation in secondary priorities. Conclusions and Relevance: In this survey study of health care professionals, preferences for infection control practices varied across income levels and geographic regions, reflecting the need for further research to better understand contextual factors influencing infection prevention and control decision-making, particularly in low- and middle-income settings. Strengthening economic evidence and tailored implementation support may promote sustainable adoption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.